Daniel J Smit

30PUBLICATIONS

47CO-AUTHORS

Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jul 12, 2026

Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.

|Apr 27, 2026

The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.

|Feb 04, 2026

Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.

Julian Kött, Nina Matthes, Alexander T Bauer

|Jan 21, 2026

Circulating cellular communication network factor 1 (CCN1) as a liquid biopsy marker indicating progression in advanced melanoma.

Isabel Heidrich, Kim-Lea Reese, Helen Ullemeyer

|Dec 12, 2025

Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Nov 29, 2025

Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.

Jialei Weng, Feng Ju, Zicheng Lyu

Pageof 5

Frequent Collaborators

10 joint publications

Klaus Pantel

Manfred Jücker

Glenn Geidel

Christoffer Gebhardt

Julian Kött

Tim Zell

Hanna Taipaleenmäki

Stefan W Schneider

Isabel Heidrich

Catherine Alix-Panabières

Frequent Collaborators

10 joint publications

Klaus Pantel

8 joint publications

Manfred Jücker

5 joint publications

Glenn Geidel

5 joint publications

Christoffer Gebhardt